Health Care: Drugs

Regeneron Pharmaceuticals Inc (REGN: NASDAQ)

$398.93 2.71 | 0.68%
05/31/16 - 03:59 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 4.10B 2.82B 2.10B 1.38B
Cost of Sales 317.80M 152.33M 114.15M 47.52M
Gross Operating Profit 3.79B 2.67B 1.99B 1.33B
Selling, General, and Administrative Expenses 838.53M 504.75M 329.42M 210.75M
Research & Development 1.62B 1.27B 859.95M 625.55M
Operating Income before D & A (EBITDA) 1.33B 891.12M 801.23M 494.65M
Depreciation & Amortization 74.91M 52.69M 41.20M 36.94M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -12.58M -25.31M -231.00K 2.01M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 1.24B 813.12M 759.80M 459.73M
Interest Expense 14.24M 37.37M 46.44M 45.30M
Pre-Tax Income 1.23B 775.75M 713.36M 414.42M
Income Taxes 589.04M 427.67M 289.00M -335.85M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 636.06M 348.07M 424.36M 750.27M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 636.06M 348.07M 424.36M 750.27M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 636.06M 348.07M 424.36M 750.27M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
636.06M 348.07M 424.36M 750.27M
Preferred Dividends
Net Income Available To Common 636.06M 348.07M 424.36M 750.27M
Basic EPS from Continuing Ops. 6.17 3.46 4.33 7.92
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 6.17 3.46 4.33 7.92
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 6.17 3.46 4.33 7.92
Basic Normalized Net Income/Share 6.17 3.46 4.33 7.92
EPS fr Continuing Ops. 5.52 3.07 3.81 6.50
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 5.52 3.07 3.81 6.50
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.25
EPS, Total 5.52 3.07 3.81 6.75
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.52 3.07 3.81 6.50
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with REGN

Latest REGN Headlines from TheStreet

More Financial News for REGN

Press Releases for REGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter